DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
|You are receiving this because you have an account on www.oneGRAVESvoice.com|
|To unsubscribe from these emails, click here|
Trusted Resources: News & Meetings
Latest announcements and gatherings
Infants born to women who received antithyroid drugs (ATDs) for Graves disease (GD) during the first trimester of pregnancy have an increased risk for congenital malformations, a study has found.
“ATD exposure during the first trimester was associated with significantly increased risk for congenital malformations, particularly for pregnancies in which women received prescriptions for MMI [methimazole] or both ATDs” (MMI or propylthiouracil [PTU]), the researchers write.
Gi Hyeon Seo, MD, from Health Insurance Review and Assessment Service, Wonju-si, Gangwon-do, Korea, and colleagues published their findings online today in Annals of Internal Medicine.
The authors note, however, that the risk to the fetus must be balanced against the mothers’ risks. “Untreated or insufficiently treated GD may result in pregnancy loss and serious fetal and maternal sequelae, providing a compelling indication for timely administration of antithyroid drugs,” the researchers explain.
People & PlacesThe University of Texas Southwestern Medical CenterThe specialized endocrinologists and end...
Evidence & EducationCancer Mortality Following Treatment for Adult HyperthyroidismContext: High-dose iodine 131 is the tr...
Evidence & EducationSubclinical Hypothyroidism After 131I-Treatment of Graves’ Disease: A Risk Factor for Depression?Objectives: Although it is well accepte...
Evidence & EducationGraves’ Disease Following Immune Reconstitution or Immunomodulatory Treatment: Should We Manage it any Differe...Graves' disease and other disorders of t...
Evidence & EducationFor Parents: Hyperthyroidism and Graves’ DiseaseWhat is the Thyroid? The thyroid is a s...
Evidence & EducationPatients’ Perceptions and Views of Surgery and Radioiodine Ablation in the Definitive Management of GravesR...Background: Patients' perceptions and p...
Evidence & EducationGraves’ Disease and PregnancyHypothyroidism During Pregnancy At firs...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.